Results 111 to 120 of about 26,249 (178)

Progression of biological markers in spinocerebellar ataxia type 3: longitudinal analysis of prospective data from the ESMI cohort. [PDF]

Lancet Reg Health Eur
Berger M, Garcia-Moreno H, Ferreira M, Hubener-Schmid J, Schaprian T, Wegner P, Elter T, Teichmann KM, Santana MM, Grobe-Einsler M, Oender D, Koyak BSC, Bernsen S, Pereira de Almeida L, Silva P, Ribeiro JA, Cunha I, Gonzalez-Robles C, Khan S, Heslegrave A, Zetterberg H, Lima M, Raposo M, Ferreira AF, Vasconcelos J, van de Warrenburg BP, van Gaalen J, van Prooije TH, de Vries J, Schols L, Riess O, Synofzik M, Timmann D, Thieme A, Erdlenbruch F, Infante J, Pelayo-Negro AL, Manrique L, Reetz K, Dogan I, Oz G, Joers JM, Bushara K, Onyike C, Povazan M, Jacobi H, Schmahmann JD, Ratai EM, Schmid M, Giunti P, Klockgether T, Faber J.   +51 more
europepmc   +1 more source

“Mimicking” capacity of spinocerebellar ataxia type 3: The details matter

Journal of the Neurological Sciences, 2013
Conceição, Bettencourt, Manuela, Lima
openaire   +2 more sources

Beyond the cerebellum: perivascular space burden in spinocerebellar ataxia type 3 extends to multiple brain regions. [PDF]

Brain Commun
Huang Y, Zhen Z, Deng L, Ou P, Shi L, Shi F, Hua R, Wu J, Chen W, Wen R, Wang J, Liu C.   +11 more
europepmc   +1 more source

Long-read sequencing identifies ATXN3 repeat expansions, and transcriptomics reveals disease progression biomarkers and druggable targets for spinocerebellar ataxia type 3. [PDF]

BMC Neurol
Liu C, Wang X, Xu C, Liu X, Ke L, Li Y, Zhang H, Tan J, Tan S, Zhang Z, Cheng L, Ren Y, Shi L.   +12 more
europepmc   +1 more source

Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3. [PDF]

J Neurol
Elter TL, Sturm D, Santana MM, Schaprian T, Raposo M, Melo ARV, Lima M, Koyak B, Oender D, Grobe-Einsler M, Lopes S, Silva P, de Almeida LP, Giunti P, Garcia-Moreno H, Nethisinhe S, de Vries J, van de Warrenburg BP, van Gaalen J, Synofzik M, Schöls L, Reetz K, Erdlenbruch F, Jacobi H, Infante J, Riess O, Klockgether T, ESMI study group, Faber J, Hübener-Schmid J.   +29 more
europepmc   +1 more source

Long-term globus pallidus internus deep brain stimulation in a young patient with spinocerebellar ataxia type 3 initially presenting with levodopa-responsive parkinsonism: a 6-year follow-up case report and literature review. [PDF]

Ther Adv Neurol Disord
Zhao J, Ma S, Gao Y, Chen J, Chen J, Shi C, Wang P, Li J, Du J, Wan Z.   +9 more
europepmc   +1 more source

Gray Matter Asymmetry Alterations in Patients With Spinocerebellar Ataxia Type 3: A Voxel-Based Morphometric Comparison Study. [PDF]

CNS Neurosci Ther
Shi L, Ou L, Ou P, Deng L, Huang Y, Wang X, Gui L, Wang B, Dai L, Ma G, Wang J, Liu C.   +11 more
europepmc   +1 more source

7T magnetic resonance imaging-based investigation of the correlation between mammillary body structure and cognitive impairment in patients with spinocerebellar ataxia type 3. [PDF]

Psychoradiology
Li C, Peng Y, Ou P, Wen R, Chen W, Tian C, Zhen Z, Wang X, Ou L, Liu C, Wang B.   +10 more
europepmc   +1 more source

Feasibility of repetitive transcranial magnetic stimulation on non-motor symptoms of spinocerebellar ataxia type 3: a secondary analysis of a randomized clinical trial. [PDF]

Front Neurol
Wu H, Xu HL, Liu XH, Sikandar A, Lin W, Cui ML, Kang MX, Zheng YR, Gan SR, Qiu LL.   +9 more
europepmc   +1 more source

ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3. [PDF]

Expert Rev Mol Med
Hernández-Carralero E, Quinet G, Freire R.   +2 more
europepmc   +1 more source